270 related articles for article (PubMed ID: 8331773)
1. [Enhancement of in vitro antimicrobial activity of cefmetazole and cefazolin in combination against methicillin-resistant Staphylococcus aureus studies by checkerboard MIC method and disc diffusion method using discs containing both drugs].
Matsuo K; Uete T
Jpn J Antibiot; 1993 Feb; 46(2):130-41. PubMed ID: 8331773
[TBL] [Abstract][Full Text] [Related]
2. [Enhancement of in vitro antimicrobial activity of cefmetazole and cefotiam in combination against methicillin-susceptible and -resistant Staphylococcus aureus studied using checkerboard MIC method and disc diffusion method with discs containing both drugs].
Matsuo K; Uete T
Jpn J Antibiot; 1993 Mar; 46(3):222-33. PubMed ID: 8510319
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of in vitro antimicrobial activity of cefazolin alone and in combination with cefmetazole or flomoxef using agar dilution method and disk diffusion method].
Matsuo K; Uete T
Jpn J Antibiot; 1992 Oct; 45(10):1253-66. PubMed ID: 1479676
[TBL] [Abstract][Full Text] [Related]
4. Synergistic enhancement of in vitro antimicrobial activity of cefmetazole and cefazolin, cefotiam, cefamandole or cefoperazone in combination against methicillin-sensitive and -resistant Staphylococcus aureus. I. Effect of NaCl.
Uete T; Matsuo K
Jpn J Antibiot; 1995 Apr; 48(4):553-62. PubMed ID: 7783318
[TBL] [Abstract][Full Text] [Related]
5. [Antimicrobial activity of fosfomycin against beta-lactamase-producing methicillin-sensitive Staphylococcus aureus and methicillin-sensitive coagulase-negative staphylococci].
Hara T; Araake M; Tsuruoka T; Watabe H
Jpn J Antibiot; 2003 Apr; 56(2):142-7. PubMed ID: 12825415
[TBL] [Abstract][Full Text] [Related]
6. [Surveillance of susceptibility of clinical isolates to cefmetazole between 2000 and 2002].
Abe T; Sato Y; Sei M
Jpn J Antibiot; 2003 Dec; 56(6):574-83. PubMed ID: 15007873
[TBL] [Abstract][Full Text] [Related]
7. Synergistic enhancement of in vitro antimicrobial activity of imipenem and cefazolin, cephalothin, cefotiam, cefamandole or cefoperazone in combination against methicillin-sensitive and -resistant Staphylococcus aureus.
Uete T; Matsuo K
Jpn J Antibiot; 1995 Mar; 48(3):402-8. PubMed ID: 7752453
[TBL] [Abstract][Full Text] [Related]
8. [Studies on phage type, beta-lactamase activity and sensitivity of multiple drug-resistant Staphylococcus aureus isolated from clinical specimens to cefmetazole].
Toyonaga Y; Kurosu Y; Sugita M; Kumagai K; Hori M; Hoshina S; Kurosaka K; Nishiyama H; Shinohara N; Takahashi T; Deguchi K 210 P
Jpn J Antibiot; 1982 Jul; 35(7):1673-85. PubMed ID: 6217356
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of in vitro activity of first, second and third generation cephem antibiotics against various pathogens isolated from clinical materials in 1983].
Matsuo K; Tsuzaki Y; Furukawa S; Uete T
Jpn J Antibiot; 1984 Jun; 37(6):1040-57. PubMed ID: 6387213
[TBL] [Abstract][Full Text] [Related]
10. Synergistic enhancement of in vitro antimicrobial activity of cefmetazole and cefotiam, cefamandole or cefoperazone in combination against methicillin-sensitive and -resistant Staphylococcus aureus. II. Effect of inoculum size.
Uete T; Matsuo K
Jpn J Antibiot; 1995 Apr; 48(4):563-70. PubMed ID: 7783319
[TBL] [Abstract][Full Text] [Related]
11. [In vitro susceptibilities of clinical isolates of Staphylococcus aureus].
Igari J; Shimoji K; Uezu N; Nakasone I; Taira K; Kakazu R
Jpn J Antibiot; 1988 Sep; 41(9):1205-11. PubMed ID: 3241323
[TBL] [Abstract][Full Text] [Related]
12. [Antibacterial activity of imipenem in combination with ampicillin against methicillin-resistant strains of Staphylococcus aureus].
Saionji K; Shitara M; Miyake N; Inoue K; Kobayashi I
Jpn J Antibiot; 1990 Oct; 43(10):1685-97. PubMed ID: 2086811
[TBL] [Abstract][Full Text] [Related]
13. [Surveillance of susceptibility of clinical isolates to cefmetazole between 2000 and 2003].
Sato Y; Abe T; Koga T; Ito K; Tochikawa Y
Jpn J Antibiot; 2005 Jun; 58(3):303-16. PubMed ID: 16161756
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of sensitivity patterns of bacteria isolated from clinical materials to the 2d generation cephamycins and cephalosporins and clinical application of these antibiotics].
Matsuo K; Uete T
Jpn J Antibiot; 1983 Jul; 36(7):1621-37. PubMed ID: 6317908
[TBL] [Abstract][Full Text] [Related]
15. Combination chemotherapy for infections due to methicillin-resistant Staphylococcus aureus with combination therapy by cefuzonam and fosfomycin or minocycline in the urologic field.
Matsumoto T; Kubo S; Haraoka M; Takahashi K; Tanaka M; Sakumoto M; Kumazawa J
Clin Ther; 1993; 15(5):819-28. PubMed ID: 8269448
[TBL] [Abstract][Full Text] [Related]
16. [In vitro synergism of two-drug combinations among cefamandole, flomoxef and imipenem against MRSA].
Inoue M; Sakurai N; Matsui H; Tsunoda M; Okubo T
Jpn J Antibiot; 1990 Feb; 43(2):233-8. PubMed ID: 2362351
[TBL] [Abstract][Full Text] [Related]
17. [Clinical laboratory approach for estimating the effective administrative dose of latamoxef. Significance of a 4-category system interpretation of the latamoxef disc susceptibility test].
Uete T; Matsuo K
Jpn J Antibiot; 1987 Nov; 40(11):1906-16. PubMed ID: 3327966
[TBL] [Abstract][Full Text] [Related]
18. [Antibacterial activities of combination uses of isepamicin and beta-lactams in vitro against clinically isolated strains. Part 1. Activities against Staphylococcus aureus].
Deguchi K; Koguchi M; Suzuki Y; Tanaka S; Fukayama S; Ishihara R; Oda S
Jpn J Antibiot; 1996 Feb; 49(2):194-202. PubMed ID: 8721079
[TBL] [Abstract][Full Text] [Related]
19. [Susceptibilities of uropathogenic bacteria to ampicillin, cefazolin, cefmetazole and gentamicin. Nine-year survey of changing patterns of susceptibilities].
Igari J; Shitara M; Shitara M; Yoshimoto K; Hayashi Y
Jpn J Antibiot; 1990 Sep; 43(9):1530-7. PubMed ID: 2262960
[TBL] [Abstract][Full Text] [Related]
20. [Laboratory and clinical studies of cefmetazole in serious infection by Staphylococcus (author's transl)].
Motohiro T; Sakata Y; Fujimoto T; Nishiyama T; Ishimoto K; Tominaga K; Yamashita F; Onoda Y; Kusayanagi T; Tsuboi M; Toubo Y; Yamamoto M; Komatsu R; Tanaka C; Baba Y
Jpn J Antibiot; 1982 Mar; 35(3):821-34. PubMed ID: 6954289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
